{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T06:01:58Z","timestamp":1780293718106,"version":"3.54.0"},"reference-count":33,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"vor","delay-in-days":27,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020951","name":"Fonds de Recherche du Qu\u00e9bec","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020951","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100021338","name":"Department of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100021338","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008582","name":"McGill University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008582","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,5,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Pseudomonas aeruginosa readily evolves antimicrobial resistance through regulatory plasticity and stress-adaptive pathways. Clinically, antibiotics lacking intrinsic antipseudomonal activity are often favoured with the assumption that they avoid selective pressure on P. aeruginosa. Whether subinhibitory exposure to such \u2018non-antipseudomonal antibiotics\u2019 (NAPA) can nevertheless select for canonical resistance pathways remains incompletely defined.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Three P. aeruginosa strains (ATCC 27853 and two bloodstream isolates) were serially passaged over 14\u2005days in the presence of ertapenem, ceftriaxone or moxifloxacin at one-third the baseline MIC. MICs for antipseudomonal antibiotics (meropenem, ceftazidime, ciprofloxacin) were measured at serial time points and after a 3-day antibiotic-free recovery (Day 14). Whole-genome sequencing was performed longitudinally to identify mutations.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>NAPA exposure led to reproducible elevations in antipseudomonal MICs: ertapenem triggered up to a 29-fold increase in meropenem MIC, ceftriaxone up to a 31-fold rise in ceftazidime MIC and moxifloxacin up to a 12-fold increase in ciprofloxacin MIC. Elevated MICs persisted on Day 14 despite absence of further antibiotic pressure. Genomic analysis revealed convergent evolution of mutations in efflux regulator genes (nfxB, nalC, nalD, amrR) and the \u03b2-lactamase\u2013regulating gene dacB, emerging during periods of MIC escalation and mapping to regulatory pathways governing efflux and AmpC expression.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>Subinhibitory exposure to antibiotics without intrinsic antipseudomonal activity reproducibly selected for heritable multidrug-resistant phenotypes in P. aeruginosa. Convergent mutations arose in regulatory genes classically associated with direct antipseudomonal antibiotic pressure, demonstrating that resistance architectures can be selected independent of target engagement and underscoring the potential for collateral resistance under antibiotic stress.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/jac\/dkag182","type":"journal-article","created":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:39:36Z","timestamp":1778153976000},"source":"Crossref","is-referenced-by-count":0,"title":["<i>In vitro<\/i>\n                    exposure to non-antipseudomonal antibiotics (NAPA) induces\n                    <i>Pseudomonas aeruginosa<\/i>\n                    resistance to antipseudomonal antibiotics (APA)"],"prefix":"10.1093","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-4567-9005","authenticated-orcid":false,"given":"David","family":"Lasry","sequence":"first","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"},{"name":"Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke B","family":"Harrison","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"},{"name":"Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"},{"name":"Research Institute of the McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reggie","family":"Bamba","sequence":"additional","affiliation":[{"name":"Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Corsini","sequence":"additional","affiliation":[{"name":"Research Institute of the McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4765-3469","authenticated-orcid":false,"given":"Cedric P","family":"Yansouni","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"},{"name":"Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"},{"name":"Research Institute of the McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew P","family":"Cheng","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"},{"name":"Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"},{"name":"Research Institute of the McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2267-4239","authenticated-orcid":false,"given":"Todd C","family":"Lee","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"},{"name":"Research Institute of the McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec ,","place":["Canada"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7948-3161","authenticated-orcid":false,"given":"Alexander","family":"Lawandi","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"},{"name":"Division of Medical Microbiology, Department of Laboratory Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"},{"name":"Research Institute of the McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec ,","place":["Canada"]},{"name":"Department of Critical Care Medicine, McGill University Health Centre , Montr\u00e9al, Qu\u00e9bec , Canada"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2026,6,1]]},"reference":[{"key":"2026060101204916000_dkag182-B1","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1017\/ice.2016.174","article-title":"Antimicrobial-resistant pathogens associated with healthcare-associated infections: summary of data reported to the national healthcare safety network at the centers for disease control and prevention, 2011\u20132014","volume":"37","author":"Weiner","year":"2016","journal-title":"Infect Control Hosp Epidemiol"},{"key":"2026060101204916000_dkag182-B2","doi-asserted-by":"publisher","first-page":"732","DOI":"10.1016\/j.ajic.2025.03.005","article-title":"Community and hospital-acquired gram-negative bloodstream infections in non-ICU patients","volume":"53","author":"Keskilidou","year":"2025","journal-title":"Am J Infect Control"},{"issue":"Supplement_1","key":"2026060101204916000_dkag182-B3","doi-asserted-by":"publisher","first-page":"S81","DOI":"10.1086\/653053","article-title":"Microbial etiologies of hospital-acquired bacterial pneumonia and ventilator-associated bacterial pneumonia","volume":"51","author":"Jones","year":"2010","journal-title":"Clin Infect Dis"},{"key":"2026060101204916000_dkag182-B4","doi-asserted-by":"publisher","first-page":"E13","DOI":"10.1111\/j.1469-0691.2011.03686.x","article-title":"Nosocomial urinary tract infection in the intensive care unit: when should Pseudomonas aeruginosa be suspected? Experience of the French national surveillance of nosocomial infections in the intensive care unit, Rea-Raisin","volume":"18","author":"Venier","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"2026060101204916000_dkag182-B5","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1086\/377200","article-title":"Pseudomonas aeruginosa bacteremia: risk factors for mortality and influence of delayed receipt of effective antimicrobial therapy on clinical outcome","volume":"37","author":"Kang","year":"2003","journal-title":"Clin Infect Dis"},{"key":"2026060101204916000_dkag182-B6","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1016\/j.diagmicrobio.2017.11.022","article-title":"Antibiotic resistance rates for Pseudomonas aeruginosa clinical respiratory and bloodstream isolates among the veterans affairs healthcare system from 2009 to 2013","volume":"90","author":"Appaneal","year":"2018","journal-title":"Diagn Microbiol Infect Dis"},{"key":"2026060101204916000_dkag182-B7","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1128\/aac.00851-06","article-title":"Clinical prediction tool to identify patients with Pseudomonas aeruginosa respiratory tract infections at greatest risk for multidrug resistance","volume":"51","author":"Lodise","year":"2007","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060101204916000_dkag182-B8","doi-asserted-by":"publisher","first-page":"e0193431","DOI":"10.1371\/journal.pone.0193431","article-title":"Epidemiology and risk factors of extensively drug-resistant Pseudomonas aeruginosa infections","volume":"13","author":"Palavutitotai","year":"2018","journal-title":"PLoS One"},{"key":"2026060101204916000_dkag182-B9","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1016\/j.jhin.2010.11.024","article-title":"Imipenem and ciprofloxacin consumption as factors associated with high incidence rates of resistant Pseudomonas aeruginosa in hospitals in northern France","volume":"77","author":"Miliani","year":"2011","journal-title":"J Hosp Infect"},{"key":"2026060101204916000_dkag182-B10","doi-asserted-by":"publisher","first-page":"O188","DOI":"10.1111\/1469-0691.12362","article-title":"Exposure to ertapenem is possibly associated with Pseudomonas aeruginosa antibiotic resistance","volume":"20","author":"Cohen","year":"2014","journal-title":"Clin Microbiol Infect"},{"key":"2026060101204916000_dkag182-B11","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1093\/jac\/dky427","article-title":"Antibiotics associated with acquisition of carbapenem-resistant Pseudomonas aeruginosa in ICUs: a multicentre nested case\u2013case\u2013control study","volume":"74","author":"Coppry","year":"2019","journal-title":"J Antimicrob Chemother"},{"key":"2026060101204916000_dkag182-B12","doi-asserted-by":"publisher","first-page":"102005","DOI":"10.1016\/j.xpro.2022.102005","article-title":"Adaptive laboratory evolution of antimicrobial resistance in bacteria for genetic and phenotypic analyses","volume":"4","author":"Vinchhi","year":"2023","journal-title":"STAR Protoc"},{"key":"2026060101204916000_dkag182-B13","doi-asserted-by":"publisher","first-page":"2114","DOI":"10.1093\/bioinformatics\/btu170","article-title":"Trimmomatic: a flexible trimmer for Illumina sequence data","volume":"30","author":"Bolger","year":"2014","journal-title":"Bioinformatics"},{"key":"2026060101204916000_dkag182-B14","doi-asserted-by":"publisher","first-page":"2815","DOI":"10.1038\/s41596-022-00738-y","article-title":"Metagenome analysis using the Kraken software suite","volume":"17","author":"Lu","year":"2022","journal-title":"Nat Protoc"},{"issue":"D1","key":"2026060101204916000_dkag182-B15","doi-asserted-by":"publisher","first-page":"D646","DOI":"10.1093\/nar\/gkv1227","article-title":"Enhanced annotations and features for comparing thousands of Pseudomonas genomes in the Pseudomonas genome database","volume":"44","author":"Winsor","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026060101204916000_dkag182-B16","doi-asserted-by":"publisher","author":"Vasimuddin","DOI":"10.1109\/IPDPS.2019.00041"},{"key":"2026060101204916000_dkag182-B17","doi-asserted-by":"publisher","first-page":"1297","DOI":"10.1101\/gr.107524.110","article-title":"The genome analysis toolkit: a MapReduce framework for analyzing next-generation DNA sequencing data","volume":"20","author":"McKenna","year":"2010","journal-title":"Genome Res"},{"key":"2026060101204916000_dkag182-B18","doi-asserted-by":"publisher","first-page":"giab008","DOI":"10.1093\/gigascience\/giab008","article-title":"Twelve years of SAMtools and BCFtools","volume":"10","author":"Danecek","year":"2021","journal-title":"GigaScience"},{"key":"2026060101204916000_dkag182-B19","doi-asserted-by":"publisher","first-page":"e102","DOI":"10.1002\/cpbi.102","article-title":"Using SPAdes De Novo assembler","volume":"70","author":"Prjibelski","year":"2020","journal-title":"Curr Protoc Bioinformatics"},{"key":"2026060101204916000_dkag182-B20","doi-asserted-by":"publisher","first-page":"6614","DOI":"10.1093\/nar\/gkw569","article-title":"NCBI prokaryotic genome annotation pipeline","volume":"44","author":"Tatusova","year":"2016","journal-title":"Nucleic Acids Res"},{"key":"2026060101204916000_dkag182-B21","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1186\/s13073-024-01346-z","article-title":"Keeping up with the pathogens: improved antimicrobial resistance detection and prediction from Pseudomonas aeruginosa genomes","volume":"16","author":"Madden","year":"2024","journal-title":"Genome Med"},{"key":"2026060101204916000_dkag182-B22","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3389\/fmicb.2011.00065","article-title":"Pseudomonas Aeruginosa: resistance to the Max","volume":"2","author":"Poole","year":"2011","journal-title":"Front Microbiol"},{"key":"2026060101204916000_dkag182-B23","doi-asserted-by":"publisher","first-page":"e1000353","DOI":"10.1371\/journal.ppat.1000353","article-title":"\u03b2-Lactam resistance response triggered by inactivation of a nonessential penicillin-binding protein","volume":"5","author":"Moya","year":"2009","journal-title":"PLoS Pathog"},{"key":"2026060101204916000_dkag182-B24","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3389\/fmicb.2019.00913","article-title":"Tolerance and resistance of Pseudomonas aeruginosa biofilms to antimicrobial agents\u2014how P. aeruginosa can Escape antibiotics","volume":"10","author":"Ciofu","year":"2019","journal-title":"Front Microbiol"},{"key":"2026060101204916000_dkag182-B25","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.chembiol.2016.12.015","article-title":"Carbon sources tune antibiotic susceptibility in Pseudomonas aeruginosa via tricarboxylic acid cycle control","volume":"24","author":"Meylan","year":"2017","journal-title":"Cell Chem Biol"},{"key":"2026060101204916000_dkag182-B26","doi-asserted-by":"publisher","first-page":"e1009524","DOI":"10.1371\/journal.pgen.1009524","article-title":"Trehalose and \u03b1-glucan mediate distinct abiotic stress responses in Pseudomonas aeruginosa","volume":"17","author":"Woodcock","year":"2021","journal-title":"PLoS Genet"},{"key":"2026060101204916000_dkag182-B27","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1086\/599360","article-title":"Dynamics of adaptive microevolution of hypermutable Pseudomonas aeruginosa during chronic pulmonary infection in patients with cystic fibrosis","volume":"200","author":"Hoboth","year":"2009","journal-title":"J Infect Dis"},{"key":"2026060101204916000_dkag182-B28","doi-asserted-by":"publisher","first-page":"254","DOI":"10.1038\/s42003-023-04609-4","article-title":"Ygfb increases \u03b2-lactam resistance in Pseudomonas aeruginosa by counteracting AlpA-mediated ampDh3 expression","volume":"6","author":"Eggers","year":"2023","journal-title":"Commun Biol"},{"key":"2026060101204916000_dkag182-B29","doi-asserted-by":"publisher","first-page":"15779","DOI":"10.3390\/ijms232415779","article-title":"Role of efflux pumps on antimicrobial resistance in Pseudomonas aeruginosa","volume":"23","author":"Lorusso","year":"2022","journal-title":"Int J Mol Sci"},{"key":"2026060101204916000_dkag182-B30","doi-asserted-by":"publisher","first-page":"2458","DOI":"10.1097\/CCM.0b013e318225756d","article-title":"Antibiotic exposure and resistance development in Pseudomonas aeruginosa and Enterobacter species in intensive care units","volume":"39","author":"Ong","year":"2011","journal-title":"Crit Care Med"},{"key":"2026060101204916000_dkag182-B31","doi-asserted-by":"publisher","first-page":"4229","DOI":"10.1128\/aac.00434-16","article-title":"Dynamics of mutations during development of resistance by Pseudomonas aeruginosa against five antibiotics","volume":"60","author":"Feng","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060101204916000_dkag182-B32","doi-asserted-by":"publisher","first-page":"2543","DOI":"10.1128\/aac.49.6.2543-2545.2005","article-title":"Selection of cross-resistance following exposure of Pseudomonas aeruginosa clinical isolates to ciprofloxacin or cefepime","volume":"49","author":"Alyaseen","year":"2005","journal-title":"Antimicrob Agents Chemother"},{"key":"2026060101204916000_dkag182-B33","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1556\/030.64.2017.012","article-title":"A deletion mutation in nfxB of in vitro-induced moxifloxacin-resistant Pseudomonas aeruginosa confers multidrug resistance","volume":"64","author":"Thai","year":"2017","journal-title":"Acta Microbiol Immunol Hung"}],"container-title":["Journal of Antimicrobial Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/6\/dkag182\/68440286\/dkag182.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/jac\/article-pdf\/81\/6\/dkag182\/68440286\/dkag182.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T05:20:52Z","timestamp":1780291252000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/jac\/article\/doi\/10.1093\/jac\/dkag182\/8698986"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,5]]},"references-count":33,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,5,5]]}},"URL":"https:\/\/doi.org\/10.1093\/jac\/dkag182","relation":{},"ISSN":["0305-7453","1460-2091"],"issn-type":[{"value":"0305-7453","type":"print"},{"value":"1460-2091","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,6]]},"published":{"date-parts":[[2026,5,5]]},"article-number":"dkag182"}}